Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

医学 临床试验 放射治疗 肿瘤科 内科学 德尔菲法 疾病 医学物理学 重症监护医学 数学 统计
作者
Matthias Gückenberger,Yolande Lievens,Angelique B. Bouma,Laurence Collette,André Dekker,Nandita M. deSouza,Anne‐Marie C. Dingemans,Béatrice Fournier,Coen Hurkmans,Frédéric Lecouvet,Icro Meattini,Alejandra Romero,Umberto Ricardi,Nicola S. Russell,Daniel H. Schanne,Marta Scorsetti,Bertrand Tombal,Dirk Verellen,Christine Verfaillie,Piet Ost
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:21 (1): e18-e28 被引量:1011
标识
DOI:10.1016/s1470-2045(19)30718-1
摘要

Summary

Oligometastatic disease has been proposed as an intermediate state between localised and systemically metastasised disease. In the absence of randomised phase 3 trials, early clinical studies show improved survival when radical local therapy is added to standard systemic therapy for oligometastatic disease. However, since no biomarker for the identification of patients with true oligometastatic disease is clinically available, the diagnosis of oligometastatic disease is based solely on imaging findings. A small number of metastases on imaging could represent different clinical scenarios, which are associated with different prognoses and might require different treatment strategies. 20 international experts including 19 members of the European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer OligoCare project developed a comprehensive system for characterisation and classification of oligometastatic disease. We first did a systematic review of the literature to identify inclusion and exclusion criteria of prospective interventional oligometastatic disease clinical trials. Next, we used a Delphi consensus process to select a total of 17 oligometastatic disease characterisation factors that should be assessed in all patients treated with radical local therapy for oligometastatic disease, both within and outside of clinical trials. Using a second round of the Delphi method, we established a decision tree for oligometastatic disease classification together with a nomenclature. We agreed oligometastatic disease as the overall umbrella term. A history of polymetastatic disease before diagnosis of oligometastatic disease was used as the criterion to differentiate between induced oligometastatic disease (previous history of polymetastatic disease) and genuine oligometastatic disease (no history of polymetastatic disease). We further subclassified genuine oligometastatic disease into repeat oligometastatic disease (previous history of oligometastatic disease) and de-novo oligometastatic disease (first time diagnosis of oligometastatic disease). In de-novo oligometastatic disease, we differentiated between synchronous and metachronous oligometastatic disease. We did a final subclassification into oligorecurrence, oligoprogression, and oligopersistence, considering whether oligometastatic disease is diagnosed during a treatment-free interval or during active systemic therapy and whether or not an oligometastatic lesion is progressing on current imaging. This oligometastatic disease classification and nomenclature needs to be prospectively evaluated by the OligoCare study.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hello的应助被专注的念烟采纳,获得10
刚刚
临猗下大雨完成签到,获得积分10
刚刚
小蘑菇的应助被专注的念烟采纳,获得10
刚刚
奋斗的大白菜完成签到,获得积分10
刚刚
yunwen完成签到,获得积分10
刚刚
斯文败类的应助被专注的念烟采纳,获得10
刚刚
研友_VZG7GZ的应助被专注的念烟采纳,获得10
刚刚
CipherSage的应助被直率的问薇采纳,获得10
1秒前
1秒前
共享精神的应助被专注的念烟采纳,获得10
1秒前
lili完成签到,获得积分10
1秒前
Eric完成签到,获得积分10
1秒前
JamesPei的应助被专注的念烟采纳,获得10
1秒前
所所的应助被专注的念烟采纳,获得10
1秒前
无花果的应助被2222采纳,获得30
1秒前
我是老大的应助被专注的念烟采纳,获得10
1秒前
完美世界的应助被专注的念烟采纳,获得10
1秒前
LL完成签到,获得积分10
2秒前
安琪完成签到,获得积分10
2秒前
2秒前
高兴巧克力完成签到,获得积分10
3秒前
3秒前
华无剑的应助被呆萌忆秋采纳,获得10
3秒前
小骨仙完成签到 ,获得积分10
3秒前
3秒前
顾建瑜完成签到,获得积分10
4秒前
4秒前
5秒前
朴实的灵萱完成签到 ,获得积分10
5秒前
顾建瑜发布了新的文献求助10
6秒前
哈哈完成签到,获得积分20
6秒前
小涵完成签到,获得积分10
6秒前
7秒前
今天不熬夜完成签到 ,获得积分10
7秒前
溜溜梅完成签到,获得积分10
7秒前
快乐小猫咪完成签到,获得积分20
7秒前
why完成签到,获得积分10
7秒前
吃火龙果不吐米米完成签到 ,获得积分10
7秒前
苦尽甘来完成签到,获得积分10
7秒前
水水发布了新的文献求助50
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173474
求助须知:如何正确求助?哪些是违规求助? 9565719
关于积分的说明 21781727
捐赠科研通 7767700
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476832